IP Library Granted Patent US 8,292,068
Granted Patent B2
US 8,292,068 · App. 13/292,129 · Granted Oct 23, 2012

Medical device package

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,292,068
App. No.
13/292,129
Granted
Oct 23, 2012
Kind
B2
Abstract

The present disclosure provides a package for a medical device containing a cavity for receiving the medical device, a first closure having a sealed portal therein and a second closure adjacent the first closure.

Claims (23)

1. A package for a medical device, the package comprising:

a medical device;

a package housing defining a cavity configured and dimensioned to receive the medical device;

a first closure positioned at a proximal end of the package housing and movable from an open position to a closed position for sealing the medical device within the cavity, the first closure having a self-sealing injectable hub therein which maintains sterility of the package when accessing the medical device, and,

a second closure positioned at a distal end of the package housing opposite the proximal end of the package housing.

2. The package of claim 1 wherein the medical device is selected from the group consisting of sutures, staples, clips, pledgets, buttresses, suture anchors, cables, wires, pacemakers, stents, catheters, inflatable devices, adhesives, sealants, meshes, sternum closures, pins, screws, tacks, rods, plates, adhesion barriers, bioelectronic devices, dental implants, surgical tools and combinations thereof.

3. The package of claim 1 wherein the medical device is a suture.

4. The package of claim 1 further comprising at least one agent selected from the group consisting of drugs, coating materials, diluents, wound healing agents, adhesives, sealants, blood products, blood components, preservatives, colorants, dyes, ultraviolet absorbers, ultraviolet stabilizers, photochromic agents, anti-adhesive agents, proteins, polysaccharides, peptides, genetic material, viral vectors, nucleic acids, nucleotides, plasmids, lymphokines, radioactive agents, cross-linking agents, metals, alloys, salts, growth factors, growth factor antagonists, cells, immunological agents, anti-colonization agents, diagnostic agents, imaging agents, and combinations thereof.

5. The package of claim 4 wherein the at least one agent is a drug.

6. The package of claim 5 wherein the drug is selected from the group consisting of antiseptics, anesthetics, muscle relaxants, antihistamines, decongestants, antimicrobial agents, anti-viral agents, anti-fungal agents, antimalarials, amebicides, antituberculosal agents, antiretroviral agents, leprostatics, antiprotazoals, antihelmitics, antibacterial agents, steroids, hematopoietic agents, antiplatelet agents, anticoagulants, coagulants, thrombolytic agents, hemorrheologic agents, hemostatics, plasma expanders, hormones, sex hormones, uterine-active agents, bisphosphonates, antidiabetic agents, glucose-elevating agents, growth hormones, thyroid hormones, inotropic agents, antiarrhythmic agents, calcium channel blockers, vasodilators, sympatholytics, antihyperlipidemic agents, vasopressors, angiotensin antagonists, sclerosing agents, anti-impotence agents, urinary alkanizers, urinary acidifiers, anticholinergics, diuretics, bronchodilators, surfactants, antidepressants, antipsychotics, antianxiety agents, sedatives, hypnotics, barbiturates, antiemetic agents, analgesics, stimulants, anticonvulsants, antiparkinson agents, proton pump inhibitors, H2-antagonists, antispasmodics, laxatives, antidiarrheals, antiflatulents, digestive enzymes, gallstone solubilizing agents, antihypertensive agents, cholesterol-lowering agents, radiopaque agents, immune globulins, monoclonal antibodies, antibodies, antitoxins, antivenins, immunologic agents, anti-inflammatory agents, antineoplastic agents, alkylating agents, antimetabolites, antimitotic agents, radiopharmaceuticals, vitamins, herbs, trace elements, amino acids, enzymes, chelating agents, immunomodulatory agents, immunosuppressive agents and combinations thereof.

7. The package of claim 4 wherein the at least one agent is a diluent selected from the group consisting of water, saline, dextrose and combinations thereof.

8. The package of claim 1 wherein the package is a monolithic structure.

9. The package of claim 1 further comprising at least one guide member positioned within the cavity.

10. A method of packaging a medical device comprising: providing a medical device; and placing the medical device in the package of claim 1 .

11. A packaged medical device comprising:

a surgical mesh;

a cavity configured and dimensioned to receive the surgical mesh;

a first closure movable from an open position to a closed position for sealing the surgical mesh within the cavity, the first closure having a self-sealing injectable hub therein which maintains sterility of the package when accessing the surgical mesh and the first closure positioned at a proximal end of the cavity, and a second closure positioned at a distal end of the cavity opposite the proximal end of the cavity.

12. The package of claim 11 further comprising at least one guide member positioned within the cavity.

13. The package of claim 11 further comprising at least one agent selected from the group consisting of drugs, coating materials, diluents, wound healing agents, adhesives, sealants, blood products, blood components, preservatives, colorants, dyes, ultraviolet absorbers, ultraviolet stabilizers, photochromic agents, anti-adhesive agents, proteins, polysaccharides, peptides, genetic material, viral vectors, nucleic acids, nucleotides, plasmids, lymphokines, radioactive agents, cross-linking agents, metals, alloys, salts, growth factors, growth factor antagonists, cells, immunological agents, anti-colonization agents, diagnostic agents, imaging agents, and combinations thereof.

14. The package of claim 13 wherein the at least one agent is a drug selected from the group consisting of antiseptics, anesthetics, muscle relaxants, antihistamines, decongestants, antimicrobial agents, anti-viral agents, anti-fungal agents, antimalarials, amebicides, antituberculosal agents, antiretroviral agents, leprostatics, antiprotazoals, antihelmitics, antibacterial agents, steroids, hematopoietic agents, antiplatelet agents, anticoagulants, coagulants, thrombolytic agents, hemorrheologic agents, hemostatics, plasma expanders, hormones, sex hormones, uterine-active agents, bisphosphonates, antidiabetic agents, glucose-elevating agents, growth hormones, thyroid hormones, inotropic agents, antiarrhythmic agents, calcium channel blockers, vasodilators, sympatholytics, antihyperlipidemic agents, vasopressors, angiotensin antagonists, sclerosing agents, anti-impotence agents, urinary alkanizers, urinary acidifiers, anticholinergics, diuretics, bronchodilators, surfactants, antidepressants, antipsychotics, antianxiety agents, sedatives, hypnotics, barbiturates, antiemetic agents, analgesics, stimulants, anticonvulsants, antiparkinson agents, proton pump inhibitors, H2-antagonists, antispasmodics, laxatives, antidiarrheals, antiflatulents, digestive enzymes, gallstone solubilizing agents, antihypertensive agents, cholesterol-lowering agents, radiopaque agents, immune globulins, monoclonal antibodies, antibodies, antitoxins, antivenins, immunologic agents, anti-inflammatory agents, antineoplastic agents, alkylating agents, antimetabolites, antimitotic agents, radiopharmaceuticals, vitamins, herbs, trace elements, amino acids, enzymes, chelating agents, immunomodulatory agents, immunosuppressive agents and combinations thereof.

15. The package of claim 13 wherein the at least one agent is a diluent selected from the group consisting of water, saline, dextrose and combinations thereof.

16. The package of claim 11 wherein the package is a monolithic structure.

Assignments (2)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2011
From: STOPEK, JOSHUA B.; KIRSCH, DAVID
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 027197/0100 →